Loading organizations...
Lexigram is a technology company.
Lexigram provides a specialized data API for healthcare, powered by its proprietary medical knowledge graph. This technology leverages natural language processing and machine learning to precisely extract and contextualize clinical entities like drugs and diseases from patient records. The platform simplifies management of complex healthcare data, including unstructured formats, offering essential tools for developers.
Established in 2014 by co-founders Manuel Salvadores and Paul Alexander, Lexigram emerged from the insight that extensive healthcare data is underutilized due to fragmentation. Both experienced in scaling data platforms, Salvadores and Alexander envisioned a solution to intelligently organize and unlock this critical medical information's value.
Lexigram targets healthcare providers, payers, and vendors seeking actionable intelligence from vast datasets, encompassing patient and clinical data. Its vision is to enhance how organizations leverage their data. By offering powerful tools simplifying data complexities, Lexigram empowers users to develop innovative applications and drive data-driven decisions, improving patient care and operational efficiency.
Lexigram has raised $2.0M across 1 funding round.
Lexigram has raised $2.0M in total across 1 funding round.
# High-Level Overview
Lexigram is a healthcare data intelligence company that transforms unstructured clinical data into structured, actionable insights through natural language processing and machine learning APIs.[1] Founded in 2015 and based in San Francisco, California, Lexigram serves healthcare organizations, data scientists, and developers who need to extract meaningful information from complex medical records.[1][2]
The company addresses a critical pain point in healthcare: the vast majority of clinical data exists in unstructured formats—patient notes, faxed documents, PDFs—that are difficult to analyze at scale.[4] Lexigram's core product is a data API that extracts clinical entities (drugs, diseases, symptoms) from unstructured text while preserving contextual relationships.[1][4] This enables healthcare providers, payers, and technology vendors to unlock insights from electronic health records (EHRs) for analytics, machine learning, and operational decision-making.[1] The company has raised $2 million in seed-stage funding and operates with fewer than 25 employees, positioning itself as a specialized infrastructure provider in the healthcare technology sector.[1][2]
# Origin Story
Lexigram was founded in 2015 during a period of growing recognition that healthcare data—despite being abundant—remained largely inaccessible for analytics and AI applications.[1] The company emerged from the observation that while hospitals and clinics were accumulating massive volumes of patient, clinical, and financial data, the unstructured nature of this information created a significant bottleneck for data scientists and analysts attempting to derive value from it.[3]
David Tsung serves as the company's Chief Medical Officer, bringing clinical expertise to the technical mission.[3] The founding insight was straightforward but powerful: if messy EHR data could be processed and structured in a developer-friendly way, it would unlock transformation across healthcare analytics, enabling financial analysts, researchers, and operational teams to work with clinical data at scale.[3]
# Core Differentiators
# Role in the Broader Tech Landscape
Lexigram operates at the intersection of three powerful trends: the digitization of healthcare, the explosion of unstructured data, and the maturation of AI/ML infrastructure.
Healthcare organizations are under increasing pressure to derive value from their data investments—whether for improving patient outcomes, reducing operational costs, or enabling predictive analytics.[1][4] However, the gap between data availability and data usability remains vast. Lexigram fills this gap by providing specialized infrastructure that generic data tools cannot address, given the complexity and regulatory sensitivity of clinical information.
The company's timing is particularly relevant as healthcare systems accelerate digital transformation and as machine learning becomes central to clinical decision support, population health management, and research. By making clinical data accessible to developers and data scientists, Lexigram enables a broader ecosystem of healthcare applications—from analytics platforms to AI-driven diagnostic tools to telemedicine systems.[1][4]
In the broader startup ecosystem, Lexigram represents the category of specialized infrastructure companies—tools built for specific domains (healthcare) that solve problems too niche for general-purpose platforms but too important for enterprises to ignore. This positioning gives the company leverage with enterprise customers while maintaining focus on a defensible market.
# Quick Take & Future Outlook
Lexigram's future depends on several converging factors. The healthcare industry's continued investment in data analytics and AI will create sustained demand for clinical data extraction capabilities.[1] Regulatory pressures around data interoperability and the rise of health information exchanges may also accelerate adoption, as organizations seek standardized ways to structure and share clinical data.
The company's small team and modest funding to date suggest it remains in early-stage growth, likely focused on product-market fit and customer acquisition within healthcare technology vendors and progressive health systems. As healthcare organizations increasingly adopt machine learning and analytics platforms, the demand for reliable clinical data infrastructure will likely grow—positioning Lexigram as a foundational layer in the healthcare AI stack.
The key question for Lexigram's trajectory is whether it can scale its proprietary knowledge graph and API infrastructure to handle the diversity and volume of clinical data across different healthcare systems, while maintaining the contextual accuracy that differentiates it from simpler NLP approaches. Success would establish Lexigram as an essential utility in healthcare data infrastructure—the kind of specialized tool that becomes embedded in enterprise workflows and difficult to displace.
Lexigram has raised $2.0M in total across 1 funding round.
Lexigram's investors include Storm Ventures, RTAventures, Stanford.
Lexigram has raised $2.0M across 1 funding round. Most recently, it raised $2.0M Seed in November 2016.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Nov 1, 2016 | $2.0M Seed | Storm Ventures | RTAventures, Stanford |